About simoctoco g alfa recombina
Recombinant factor VIII clotting factor
Used for
- Treating and preventing bleeding in haemophilia A
- Preventing bleeding during surgery in haemophilia A
Usual adult dose
Individualised by body weight, bleeding severity, and response; often 20–50 IU/kg per dose, repeated as needed.
Usual dose in children
Individualised by body weight and response; often 20–50 IU/kg per dose, repeated as needed.
Common side effects
- Headache
- Injection-site reactions
- Fever
- Development of factor VIII inhibitors
Important warnings
- Factor VIII inhibitors can reduce treatment effectiveness and cause persistent bleeding.
- Severe allergic reactions can occur; stop treatment and seek urgent care if symptoms develop.
- Dose and monitoring should be guided by a haemophilia specialist.
- Not for von Willebrand disease.
Pregnancy
Limited pregnancy data; use only when clearly needed and under specialist supervision.
Breastfeeding
Limited data; use only when clearly needed and under specialist supervision.
AI-generated from general medical knowledge, not from this product's official leaflet. It may be incomplete or out of date. Not medical advice — ask a pharmacist or doctor before making any decision.